JP Nadda launches National Viral Hepatitis Control Programme

This initiative will provide laboratory testing and management of viral hepatitis with a de-centralised approach

“With this initiative, government is strongly committed to work towards elimination of viral hepatitis by 2030.” This was stated by JP Nadda, Union Minister of Health and Family Welfare as he launched the National Viral Hepatitis Control Programme to mark the World Hepatitis Day, 2018, recently. At the function, JP Nadda also released the Operational Guidelines for National Viral Hepatitis Control Programme, National Laboratory Guidelines for Viral Hepatitis Testing and National Guidelines for Diagnosis and Management of Viral Hepatitis. Manoj Sinha, MoS (Independent Charge), Ministry of Communication also released the commemorative Stamp at the occasion.

Ashwini Kumar Choubey and Anupriya Patel, Ministers of State for Health and Family Welfare along with Preeti Sudan, Secretary (Health), Ananta Narayan Nanda, Secretary, Dept. of Posts and Dr S Venkatesh, DGHS were also present at the launch function.

Addressing the participants, Nadda said that under the guidance of Honourable Prime Minister, Narendra Modi the ministry is aggressively addressing the preventable diseases. JP Nadda said that there has been a paradigm shift in designing the programme. “Programmes are now designed at the ground level and all stakeholders are taken into the consideration. We are now making sure that every last person gets the benefit out of it,” he said.

Nadda further said that the ministry has already launched a campaign to end TB by 2025, five years ahead of global target. He said that the government now has more than 1100 CBNAAT machines for rapid diagnosis of TB and provides daily regimen with fixed dose combinations. He further said that the programme has also initiated active case finding to screen more TB patients.

Nadda stated that the government has also launched the ‘Test and Treat Policy for HIV’ wherein as soon as a person is tested and found to be positive, he will be provided with ART irrespective of his CD count or clinical stage. Adding further, he said that the government has also launched Rotavirus vaccine, Pneumococcal Conjugate Vaccine (PCV), and the Measles-Rubella (MR), Pneumonia vaccine and one thing that was remaining was Hepatitis and with this launch free drugs and diagnostics for hepatitis B & C will be offered. “This initiative will provide laboratory testing and management of viral hepatitis with a de-centralised approach,” Nadda said.

Choubey said that awareness is a very important component of the programme. This will help to find the disease carriers and towards their diagnosis and treatment. “This exemplifies India’s commitment to providing universal health coverage and meeting SDG targets for the country,” Choubey said. Speaking at the function, Manoj Sinha stated that the Department of Posts (DoP) has released several stamps to generate awareness about various programmes of the government. He further informed the participants about various initiatives of DoP.

Patel stated that National Viral Control Programme marks the beginning of the nation’s journey to control viral hepatitis thereby reducing mortality and morbidity attributed to it. “It is envisaged that this programme will reach large number of people possibly harbouring the infection. Integrating the intervention within the existing health systems framework under NHM rather than adopting a vertical approach will further complement our efforts in providing more comprehensive care till the grass root level.”

MoHFW has launched the ‘National Viral Hepatitis Control Programme’, with the goal of ending viral hepatitis as a public health threat by 2030 in the country. The aim of the initiative is to reduce morbidity and mortality due to viral hepatitis. The key strategies include preventive and promotive interventions with focus on awareness generation, safe injection practices and socio-cultural practices, sanitation and hygiene, safe drinking water supply, infection control and immunisation; building capacities at national, state, district levels and sub-district level up to Primary Health Centres (PHC) and health and wellness centres such that the programme can be scaled up till the lowest level of the healthcare facility in a phased manner.

Also present at the event were, Manoj Jhalani, AS & MD (NHM), Dr Henk Bekedam, WHO representative to India along with the senior officers from the ministry and the states.